Ovid Therapeutics Inc.OVID

Market cap

$95.29M

P/E ratio

	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	87	36	42	72	190	47	29	28
Marketable securities, current	-	5	35	-	-	84	79	27
Total cash & short-term investments	87	42	77	72	190	131	108	55
Total current assets	89	44	80	75	190	131	110	56
Property, plant and equipment, net	51,775	69,867	68,363	135,620	242,757	1	768,753	0
Marketable securities, non-current	-	-	-	-	2	6	18	21
Total non-current assets	869,555	3	1	1	4	24	34	36
Total assets	89	48	81	76	195	155	144	92
Accounts payable	2	4	3	5	7	2	4	3
Total current liabilities	6	9	11	22	15	7	11	11
Total non-current liabilities	-	-	286,562	10	-	16	45	13
Total liabilities	-	-	11	32	15	23	56	24
Common stock and paid-in capital	184	24,654	54,711	65,743	351	358	366	373
Retained earnings	-100,715,668	-152,695,278	-213,156,521	-294,192,097	-171	-225	-278	-304
Stockholders' equity	83	39	70	44	180	132	88	68